Latest
The race to sequence the world - A look at Next Generation Sequencing (NGS)
Novo Nordisk (NVO) Deep Dive
All you need to know about Gene Therapy
Thermo Fisher Scientific (TMO) Deep Dive
Exploring Drug Modalities: Small Molecules, Biologics, RNA, Cell & Gene Therapy
Thank you for your support in 2022
Technologies in 5 mins
The race to sequence the world - A look at Next Generation Sequencing (NGS)
All you need to know about Gene Therapy
Exploring Drug Modalities: Small Molecules, Biologics, RNA, Cell & Gene Therapy
Can Precision Fermentation together with Synthetic Biology Help to Secure Our Food Systems?
Synthetic Biology is poised to breath new life into fermentation
The rise of plant-based meat
A deep dive into the microbiome market landscape
News
Are RSV vaccines going to be the next blockbuster vaccine to be developed?
The below graph shows that the rate of RSV-associated hospitalizations has increased significantly after the COVID pandemic (2020-2021 season).
In the 2022-2023 season, the current estimate for RSV-associated hospitalization stood at 18 per 100k people in the US. However, this is just the start of the RSV season, and the
3 Top Biotech News Of The Week (22 Oct 2022) - Oculis, LLY, AKUS, JAZZ, ZYME
A look at Nimbus & Eli Lilly's AMPK Collaboration, Regeneron and Sanofi's Dupixent EOE approval and Merck's Sotatercept for PAH
3 Top Biotech News Of The Week (8 October 22) - BMS, AUTL, DNA, Svante Pääbo discovery
3 Top Biotech News Of The Week (1 October 22)
3 Top Biotech News Of The Week (10 September 22)
3 Top Biotech News Of The Week (3 September 22)
Blog
5 Blockbuster Drugs Which Can Be Spun Out as a Company
Not all drugs are equal.
While most pharmaceutical companies talk about their pipeline programs. Some drugs alone could be pharmaceutical/biotech and still have a robust pipeline.
These drugs are usually targeting systemic pathways, enabling their use across multiple disease indications and in the process creating a pipeline for themselves.
Earnings Update for NVO, LLY & REGN
What You Need to Know About Growth Investing & Two Potential Metrics to Use
8 Gene Editing/CRISPR Companies to Consider For Your Portfolio
Thermo Fisher Scientific (TMO) a healthcare juggernaut you cannot ignore
Trading vs Investing – What’s the difference?
